相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Aducanumab and the FDA - where are we now?
Howard Fillit et al.
NATURE REVIEWS NEUROLOGY (2021)
MiR-485-3p serves as a biomarker and therapeutic target of Alzheimer's disease via regulating neuronal cell viability and neuroinflammation by targeting AKT3
Ling Yu et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2021)
PANoptosis in microbial infection
David E. Place et al.
CURRENT OPINION IN MICROBIOLOGY (2021)
Evaluation of Aducanumab for Alzheimer Disease Scientific Evidence and Regulatory Review Involving Efficacy, Safety, and Futility
G. Caleb Alexander et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
AIM2 forms a complex with pyrin and ZBP1 to drive PANoptosis and host defence
SangJoon Lee et al.
NATURE (2021)
Arf6 exacerbates allergic asthma through cell-to-cell transmission of ASC inflammasomes
SangJoon Lee et al.
JCI INSIGHT (2021)
Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines
SangJoon Lee et al.
TRENDS IN IMMUNOLOGY (2020)
Acute targeting of pre-amyloid seeds in transgenic mice reduces Alzheimer-like pathology later in life
Ruth E. Uhlmann et al.
NATURE NEUROSCIENCE (2020)
被撤回的出版物: MiR-485-3p serves as a biomarker and therapeutic target of Alzheimer's disease via regulating neuronal cell viability and neuroinflammation by targeting AKT3 (Retracted Article)
Ling Yu et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2020)
NLRP3 inflammasome activation drives tau pathology
Christina Ising et al.
NATURE (2019)
Influenza restriction factor MxA functions as inflammasome sensor in the respiratory epithelium
SangJoon Lee et al.
SCIENCE IMMUNOLOGY (2019)
Influenza A Virus Infection Triggers Pyroptosis and Apoptosis of Respiratory Epithelial Cells through the Type I Interferon Signaling Pathway in a Mutually Exclusive Manner
SangJoon Lee et al.
JOURNAL OF VIROLOGY (2018)
Tau-targeting therapies for Alzheimer disease
Erin E. Congdon et al.
NATURE REVIEWS NEUROLOGY (2018)
Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer's disease
Carmen Venegas et al.
NATURE (2017)
Microglia emerge as central players in brain disease
Michael W. Salter et al.
NATURE MEDICINE (2017)
The antibody aducanumab reduces Aβ plaques in Alzheimer's disease
Jeff Sevigny et al.
NATURE (2016)
An overview of microRNAs
Scott M. Hammond
ADVANCED DRUG DELIVERY REVIEWS (2015)
Current Thinking on the Mechanistic Basis of Alzheimer's and Implications for Drug Development
C. Ising et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Appoptosin-Mediated Caspase Cleavage of Tau Contributes to Progressive Supranuclear Palsy Pathogenesis
Yingjun Zhao et al.
NEURON (2015)
A three-dimensional human neural cell culture model of Alzheimer's disease
Se Hoon Choi et al.
NATURE (2014)
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Stephen Salloway et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
Rachelle S. Doody et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Alzheimer's disease drug-development pipeline: few candidates, frequent failures
Jeffrey L. Cummings et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
The Therapeutics of Alzheimer's Disease: Where We Stand and Where We Are Heading
J. Dennis et al.
ANNALS OF NEUROLOGY (2013)
Amyloid-β-Induced Astrocytic Phagocytosis is Mediated by CD36, CD47 and RAGE
Raasay S. Jones et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
Neuron loss in the 5XFAD mouse model of Alzheimer's disease correlates with intraneuronal Aβ42 accumulation and Caspase-3 activation
William A. Eimer et al.
MOLECULAR NEURODEGENERATION (2013)
NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice
Michael T. Heneka et al.
NATURE (2013)
Microglial Beclin 1 Regulates Retromer Trafficking and Phagocytosis and Is Impaired in Alzheimer's Disease
Kurt M. Lucin et al.
NEURON (2013)
PPARγ/RXRα-Induced and CD36-Mediated Microglial Amyloid-β Phagocytosis Results in Cognitive Improvement in Amyloid Precursor Protein/Presenilin 1 Mice
Mitsugu Yamanaka et al.
JOURNAL OF NEUROSCIENCE (2012)
Patterns of microRNA expression in normal and early Alzheimer's disease human temporal cortex: white matter versus gray matter
Wang-Xia Wang et al.
ACTA NEUROPATHOLOGICA (2011)
Microglial phagocytosis induced by fibrillar β-amyloid is attenuated by oligomeric β-amyloid: implications for Alzheimer's disease
Xiao-dong Pan et al.
MOLECULAR NEURODEGENERATION (2011)
Neuronal MicroRNA Deregulation in Response to Alzheimer's Disease Amyloid-β
Nicole Schonrock et al.
PLOS ONE (2010)
Decreased Clearance of CNS β-Amyloid in Alzheimer's Disease
Kwasi G. Mawuenyega et al.
SCIENCE (2010)
The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of β-site amyloid precursor protein-cleaving enzyme 1
Wang-Xia Wang et al.
JOURNAL OF NEUROSCIENCE (2008)
Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expression
Sebastien S. Hebert et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Connecting TNF-α signaling pathways to iNOS expression in a mouse model of Alzheimer's disease:: Relevance for the Behavioral and synaptic deficits induced by amyloid β protein
Rodrigo Medeiros et al.
JOURNAL OF NEUROSCIENCE (2007)
Triple-transgenic model of Alzheimer's disease with plaques and tangles:: Intracellular Aβ and synaptic dysfunction
S Oddo et al.
NEURON (2003)
CD36 mediates the innate host response to β-amyloid
JB El Khoury et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
分享论文
